Last updated on November 2017

Pemafibrate (K-877) to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.


Brief description of study

Pemafibrate (K-877) to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes.

Detailed Study Description

This study will compare pemafibrate (K-877) compared to placebo to discover if pemafibrate lowers cardiovascular complications such as heart attack, stroke, and death from these conditions in adults with Type II Diabetes mellitus who have elevated triglycerides and low high-density lipoprotein cholesterol (HDL-C "good cholesterol). The study will also test if the medication has other benefits for the patients and will test the safety of the study medication.

Clinical Study Identifier: TX9941

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Lydia Baker

Northern Pines Health Center, PC
Buckley, MI USA
  Connect »